A paediatric case of myopericarditis post-COVID-19 mRNA vaccine
Yükleniyor...
Tarih
2022
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Cambridge University Press
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Myopericarditis is a condition, which primarily involves the pericardium, with minimal myocardial involvement. In myopericarditis, chest pain, elevated cardiac enzymes, and electrocardiographic changes occur. Although COVID-19 mRNA vaccines significantly contribute to preventing the COVID-19 disease, rarely myocarditis and/or pericarditis may develop due to these vaccines. We present a previously healthy 14-year-old male patient who developed myopericarditis after receiving the second dose of the COVID-19 mRNA vaccine.
Açıklama
WOS:000757695200001
PMID: 35082004
PMID: 35082004
Anahtar Kelimeler
mRNA vaccines, Myopericarditis, COVID-19
Kaynak
Cardiology in the Young
WoS Q Değeri
Q4
Scopus Q Değeri
Q3
Cilt
32
Sayı
10
Künye
Türe, M., Akin, A., Demir, M. ve Akay, C (2022). A paediatric case of myopericarditis post-COVID-19 mRNA vaccine. Cardiology in the Young, 32(10), 1688-1691